NCT06954493View on ClinicalTrials.gov

Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp

PHASE1CompletedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

July 12, 2023

Primary Completion Date

November 1, 2023

Study Completion Date

November 1, 2023

Conditions

Vulvovaginal CandidiasisCandida InfectionVaginal Candidiasis

Interventions

DRUG

Ibrexafungerp

Ibrexafungerp Oral Tablet

Trial Locations (1)

72758

Woodland Research Northwest (WRN), Rogers

All Listed Sponsors

lead

Scynexis, Inc.

INDUSTRY